News

Lenny Santoro credits NIH research with saving his life longer than doctors expected. Duke Health's Dr. Daniel George warns ...
Researchers have long explored ways to prevent and treat prostate cancer, one of the most common cancers in men. For years, ...
A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...
Researchers have identified a new molecular target for treating pancreatic cancer. Scientists focused on transcription-replication conflicts (TRCs), which occur when the mechanisms responsible for ...
Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for cancer, announced a new partnership with the Experimental Drug Development ...
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...
A new FDA approval has brought a renewed sense of hope as an innovative new treatment approach is now available to ...
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...
The new drugs will be available to patients later this spring, the Ministry of Health said, and will benefit more than 450 ...
The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.
A grandad caught up in the drugs trade yet again has said, "There won't be a third time". Paul Fleming, previously convicted as a drug courier, was found with over £70,000 hidden in his car at Switch ...
On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate cancer pre-chemotherapy. Just six days ...